Technology-enabled Management Versus Usual Care for Blood Pressure

Description

Two arm parallel randomized clinical trial

Conditions

Hypertension

Talk to us

Study Overview

On this page

Study Details

Study overview

Two arm parallel randomized clinical trial

A Two-arm Parallel Randomized Clinical Trial of Implementation of Technology-enabled Management Versus Usual Care for Blood Pressure

Technology-enabled Management Versus Usual Care for Blood Pressure

Condition
Hypertension
Intervention / Treatment

-

Contacts and Locations

Palo Alto

Stanford Health Care, Palo Alto, California, United States, 94305

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 30-90 yrs.
  • * Smartphone ownership
  • * Office SBP: ≥ 140 mm Hg
  • * ≤ 2 current anti-HTN meds
  • * Able to add or dose-increase at least 2 of the following classes of medications: ACE-I/ARB, diuretic, calcium channel blocker, beta-blocker, mineralocorticoid receptor antagonists (i.e., at least 2 classes are available for addition or dose- increases after excluding intolerant medications and medications currently at maximum dose)
  • * English or Spanish-speakers
  • * Heart failure with reduced ejection fraction (EF \< 40%)
  • * ESRD (GFR \<15)
  • * Renal replacement therapy
  • * Pregnant
  • * Myocardial infarction or stroke within preceding 6 months
  • * Hospitalization for hypertensive emergency or malignant hypertension within preceding 6 months
  • * Prior solid organ transplantation
  • * At the clinical discretion of the investigators
  • * Enrolled in another clinical study

Ages Eligible for Study

30 Years to 90 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Stanford University,

Paul J Wang, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

2025-03-15